G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
GMVD was delisted on the 23rd of August, 2023.
14 hedge funds and large institutions have $551K invested in G Medical Innovations Holdings Ltd. Ordinary Shares in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
27% more funds holding
Funds holding: 11 → 14 (+3)
22% more capital invested
Capital invested by funds: $453K → $551K (+$98K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RP
Regal Partners
Sydney, NSW,
Australia
|
+$480K |
| 2 |
Goldman Sachs
New York
|
+$58.9K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$15.2K |
| 4 |
Citigroup
New York
|
+$10.8K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$8.77K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tradewinds Capital Management
Bellingham,
Washington
|
-$62K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$22.4K |
| 3 |
VF
Virtu Financial
New York
|
-$7.64K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RP
1
Regal Partners
Sydney, NSW,
Australia
| $322K | +$480K | +15,210 | New |
|
|
SSA
2
Schonfeld Strategic Advisors
New York
| $73K | +$3.6K | +114 | +3% |
|
|
3
Goldman Sachs
New York
| $40K | +$58.9K | +1,867 | New |
|
4
JP Morgan Chase
New York
| $36K | – | – | – |
|
5
Geode Capital Management
Boston,
Massachusetts
| $23K | – | – | – |
|
|
6
Citadel Advisors
Miami,
Florida
| $15K | -$22.4K | -711 | -50% |
|
|
VF
7
Virtu Financial
New York
| $11K | -$7.64K | -242 | -31% |
|
|
TSS
8
Two Sigma Securities
New York
| $10K | +$15.2K | +482 | New |
|
|
9
Bank of America
Charlotte,
North Carolina
| $7K | +$8.77K | +278 | +604% |
|
|
10
Citigroup
New York
| $7K | +$10.8K | +342 | +34,200% |
|
|
IA
11
IFG Advisors
St. Louis,
Missouri
| $6K | – | – | – |
|
|
HWM
12
HighMark Wealth Management
St. Paul,
Minnesota
| $1K | – | – | – |
|
|
TCM
13
Tradewinds Capital Management
Bellingham,
Washington
| – | -$62K | -1,392 | Closed |
|
|
14
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1K | -29 | Closed |
|
15
UBS Group
Zurich,
Switzerland
| – | +$252 | +8 | New |
|
|
HI
16
Harbour Investments
Madison,
Wisconsin
| – | +$663 | +21 | New |
|
GMVD Hedge Fund Activity: Q2 2022 in Review
14 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) for Q2 2022, worth a combined $551K — up 22% from $453K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new GMVD positions and 2 closed out — a net gain of 3 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Regal Partners, opening a new position worth an estimated $480K. The largest seller was Tradewinds Capital Management, exiting entirely with an estimated $62K sold.
- 14 institutional investors held G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) as of Q2 2022, up from 11 in Q1 2022.
- Funds reported $551K of G Medical Innovations Holdings Ltd. Ordinary Shares stock for Q2 2022, up 22% quarter-over-quarter.
- 5 funds opened new G Medical Innovations Holdings Ltd. Ordinary Shares positions in Q2 2022 and 2 closed out, a net change of +3 holders.
- The largest G Medical Innovations Holdings Ltd. Ordinary Shares buyer in Q2 2022 was Regal Partners, an estimated $480K added.
- The largest G Medical Innovations Holdings Ltd. Ordinary Shares seller in Q2 2022 was Tradewinds Capital Management, an estimated $62K sold.
Based on aggregated 13F filings for Q2 2022.